Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results.

Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) subsidiary Google DeepMind CEO Demis Hassabis said artificial intelligence could ...

When John Jumper got the call earlier this month from the Royal Swedish Academy of Sciences that he was winning the Nobel Prize, he almost didn’t answer. The director of Google DeepMind, the tech ...

Google DeepMind CEO Demis Hassabis discusses AI's transformative impact at India AI Summit, highlighting AGI, AlphaFold, and India's growing AI ecosystem.

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

After demonstrating superhuman performance in games through AlphaGo, DeepMind shifted focus to science. Its breakthrough came with AlphaFold, an AI system that predicts a protein’s three-dimensional ...

At the India AI Impact Summit 2026, Sir Demis Hassabis delivered a speech that ranged from the mysteries of ancient ...

Last month, Demis Hassabis and John Jumper of Google DeepMind were jointly awarded the 2024 Nobel Prize in Chemistry for their development of AlphaFold 3. This AI model can more accurately predict the ...

A computational biology company that started in space tech is looking to change how biopharma finds disease targets by ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser. In 2020, Google DeepMind ...

Artificial intelligence represents the biggest technological platform shift of the current era and has the potential to ...

Proteins are the microscopic workhorses of the human body, driving everything from oxygen transport to muscle contraction. Their complex 3D structures dictate their function, and understanding these ...